Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.0900
+0.0005 (0.56%)
At close: Mar 27, 2026
Vivos Market Cap
Vivos has a market cap or net worth of $43.44 million as of March 27, 2026. Its market cap has decreased by -19.58% in one year.
Market Cap
43.44M
Enterprise Value
50.59M
Revenue
48.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since September 1, 1998, Vivos's market cap has increased from 12.08M to 43.44M, an increase of 259.53%. That is a compound annual growth rate of 4.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 44.26M | 41.12% |
| Dec 31, 2025 | 31.36M | -37.86% |
| Dec 31, 2024 | 50.47M | 81.66% |
| Dec 29, 2023 | 27.78M | 73.14% |
| Dec 30, 2022 | 16.05M | -44.73% |
| Dec 31, 2021 | 29.03M | -5.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tian'an Technology Group | 168.42M |
| Zomedica | 124.26M |
| Positron | 64.38M |
| RetinalGenix Technologies | 59.54M |
| Family Office of America | 48.77M |
| CS Diagnostics | 34.02M |
| PetVivo Holdings | 25.99M |
| Guided Therapeutics | 18.45M |